Biological Trace Element Research

, Volume 187, Issue 1, pp 128–136 | Cite as

Timeline (Bioavailability) of Magnesium Compounds in Hours: Which Magnesium Compound Works Best?

  • Nazan UysalEmail author
  • Servet Kizildag
  • Zeynep Yuce
  • Guven Guvendi
  • Sevim Kandis
  • Basar Koc
  • Aslı Karakilic
  • Ulas M. Camsari
  • Mehmet Ates


Magnesium is an element of great importance functioning because of its association with many cellular physiological functions. The magnesium content of foods is gradually decreasing due to food processing, and magnesium supplementation for healthy living has become increasingly popular. However, data is very limited on the bioavailability of various magnesium preparations. The aim of this study is to investigate the bioavailability of five different magnesium compounds (magnesium sulfate, magnesium oxide, magnesium acetyl taurate, magnesium citrate, and magnesium malate) in different tissues. Following a single dose 400 mg/70 kg magnesium administration to Sprague Dawley rats, bioavailability was evaluated by examining time-dependent absorption, tissue penetration, and the effects on the behavior of the animals. Pharmacokinetically, the area under the curve calculation is highest in the magnesium malate. The magnesium acetyl taurate was found to have the second highest area under the curve calculation. Magnesium acetyl taurate was rapidly absorbed, able to pass through to the brain easily, had the highest tissue concentration level in the brain, and was found to be associated with decreased anxiety indicators. Magnesium malate levels remained high for an extended period of time in the serum. The commonly prescribed dietary supplements magnesium oxide and magnesium citrate had the lowest bioavailability when compared to our control group. More research is needed to investigate the bioavailability of magnesium malate and acetyl taurate compounds and their effects in specific tissues and on behavior.


Magnesium acetyl taurate Magnesium malate Magnesium citrate Magnesium oxide Magnesium sulfate Anxiety Brain Muscle 


Compliance with Ethical Standards

The experiments were carried out according to the Guiding Principles in the Use of Experimental Animals and approved by the Animal Care and Use Committee of the Dokuz Eylul University, School of Medicine.

Conflict of Interest

The authors declare that they have no conflict of interest.


  1. 1.
    Maguire ME, Cowan JA (2002) Magnesium chemistry and biochemistry. Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine 15(3):203–210CrossRefGoogle Scholar
  2. 2.
    Swaminathan R (2003) Magnesium metabolism and its disorders. The Clinical biochemist Reviews / Australian Association of Clinical Biochemists 24(2):47–66Google Scholar
  3. 3.
    Elin RJ (2010) Assessment of magnesium status for diagnosis and therapy. Magnes Res 23(4):S194–S198PubMedPubMedCentralGoogle Scholar
  4. 4.
    Jahnen-Dechent W, Ketteler M (2012) Magnesium basics. Clin Kidney J 5(Suppl 1):i3–i14CrossRefGoogle Scholar
  5. 5.
    Scott D, Blizzard L, Fell J, Giles G, Jones G (2010) Associations between dietary nutrient intake and muscle mass and strength in community-dwelling older adults: the Tasmanian Older Adult Cohort study. J Am Geriatr Soc 58(11):2129–2134CrossRefGoogle Scholar
  6. 6.
    Cunningham J, Rodriguez M, Messa P (2012) Magnesium in chronic kidney disease stages 3 and 4 and in dialysis patients. Clin Kidney J 5(Suppl 1):i39–i51CrossRefGoogle Scholar
  7. 7.
    Boyle NB, Lawton C, Dye L (2017) The effects of magnesium supplementation on subjective anxiety and stress—a systematic review. Nutrients 9(5)Google Scholar
  8. 8.
    Verhas M, de la Gueronniere V, Grognet JM, Paternot J, Hermanne A, Van den Winkel P, Gheldof R, Martin P, Fantino M, Rayssiguier Y (2002) Magnesium bioavailability from mineral water. A study in adult men. Eur J Clin Nutr 56(5):442–447CrossRefGoogle Scholar
  9. 9.
    Coudray C, Bellanger J, Vermorel M, Sinaud S, Wils D, Feillet-Coudray C, Brandolini M, Bouteloup-Demange C, Rayssiguier Y (2003) Two polyol, low digestible carbohydrates improve the apparent absorption of magnesium but not of calcium in healthy young men. J Nutr 133(1):90–93CrossRefGoogle Scholar
  10. 10.
    Rude RK (1993) Magnesium metabolism and deficiency. Endocrinol Metab Clin N Am 22(2):377–395CrossRefGoogle Scholar
  11. 11.
    c (1997) National research, DRI (dietary reference intakes) for calcium, phosphorus, magnesium, vitamin D, and fluoride. National Academy Press, WashingtonGoogle Scholar
  12. 12.
    Mayer A-M (1997) Historical changes in the mineral content of fruits and vegetables. Br Food J 99(6):207–211CrossRefGoogle Scholar
  13. 13.
    Thomas D (2007) The mineral depletion of foods available to us as a nation (1940-2002)—a review of the 6th edition of McCance and Widdowson. Nutr Health 19(1–2):21–55CrossRefGoogle Scholar
  14. 14.
    Fawcett WJ, Haxby EJ, Male DA (1999) Magnesium: physiology and pharmacology. Br J Anaesth 83(2):302–320CrossRefGoogle Scholar
  15. 15.
    Coudray C, Rambeau M, Feillet-Coudray C, Gueux E, Tressol JC, Mazur A, Rayssiguier Y (2005) Study of magnesium bioavailability from ten organic and inorganic Mg salts in Mg-depleted rats using a stable isotope approach. Magnes Res 18(4):215–223PubMedPubMedCentralGoogle Scholar
  16. 16.
    Bertinato J, Plouffe LJ, Lavergne C, Ly C (2014) Bioavailability of magnesium from inorganic and organic compounds is similar in rats fed a high phytic acid diet. Magnes Res 27(4):175–185PubMedPubMedCentralGoogle Scholar
  17. 17.
    Schuchardt JP, Hahn A (2017) Intestinal absorption and factors influencing bioavailability of magnesium—an update. Current nutrition and food science 13(4):260–278CrossRefGoogle Scholar
  18. 18.
    Bohn T (2008) Dietary factors influencing magnesium absorption in humans. Curr Nutr Food Sci 4(1):53–72CrossRefGoogle Scholar
  19. 19.
    Schuette SA, Lashner BA, Janghorbani M (1994) Bioavailability of magnesium diglycinate vs magnesium oxide in patients with ileal resection. JPEN J Parenter Enteral Nutr 18(5):430–435Google Scholar
  20. 20.
    Casarrubea M, Sorbera F, Crescimanno G (2009) Multivariate data handling in the study of rat behavior: an integrated approach. Behav Res Methods 41(3):772–781CrossRefGoogle Scholar
  21. 21.
    Handley SL, Mithani S (1984) Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ‘fear’-motivated behaviour. Naunyn Schmiedeberg's Arch Pharmacol 327(1):1–5CrossRefGoogle Scholar
  22. 22.
    Meyer OA, Tilson HA, Byrd WC, Riley MT (1979) A method for the routine assessment of fore- and hindlimb grip strength of rats and mice. Neurobehav Toxicol 1(3):233–236PubMedPubMedCentralGoogle Scholar
  23. 23.
    Dunham NW, Miya TS (1957) A note on a simple apparatus for detecting neurological deficit in rats and mice. Journal of the American Pharmaceutical Association American Pharmaceutical Association 46(3):208–209CrossRefGoogle Scholar
  24. 24.
    Walker AF, Marakis G, Christie S, Byng M (2003) Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study. Magnes Res 16(3):183–191PubMedPubMedCentralGoogle Scholar
  25. 25.
    Morris ME, LeRoy S, Sutton SC (1987) Absorption of magnesium from orally administered magnesium sulfate in man. J Toxicol Clin Toxicol 25(5):371–382CrossRefGoogle Scholar
  26. 26.
    Bohmer T, Roseth A, Holm H, Weberg-Teigen S, Wahl L (1990) Bioavailability of oral magnesium supplementation in female students evaluated from elimination of magnesium in 24-hour urine. Magnesium and trace elements 9(5):272–278PubMedPubMedCentralGoogle Scholar
  27. 27.
    Morais JB, Severo JS, Santos LR, de Sousa Melo SR, de Oliveira Santos R, de Oliveira AR, Cruz KJ, do Nascimento Marreiro D (2017) Role of magnesium in oxidative stress in individuals with obesity. Biol Trace Elem Res 176(1):20–26CrossRefGoogle Scholar
  28. 28.
    Murck H, Steiger A (1998) Mg2+ reduces ACTH secretion and enhances spindle power without changing delta power during sleep in men—possible therapeutic implications. Psychopharmacology 137(3):247–252CrossRefGoogle Scholar
  29. 29.
    Laarakker MC, van Lith HA, Ohl F (2011) Behavioral characterization of A/J and C57BL/6J mice using a multidimensional test: association between blood plasma and brain magnesium-ion concentration with anxiety. Physiol Behav 102(2):205–219CrossRefGoogle Scholar
  30. 30.
    Poleszak E, Szewczyk B, Kedzierska E, Wlaz P, Pilc A, Nowak G (2004) Antidepressant- and anxiolytic-like activity of magnesium in mice. Pharmacol Biochem Behav 78(1):7–12CrossRefGoogle Scholar
  31. 31.
    Iezhitsa IN, Spasov AA, Kharitonova MV, Kravchenko MS (2011) Effect of magnesium chloride on psychomotor activity, emotional status, and acute behavioural responses to clonidine, d-amphetamine, arecoline, nicotine, apomorphine, and L-5-hydroxytryptophan. Nutr Neurosci 14(1):10–24CrossRefGoogle Scholar
  32. 32.
    Magaldi M, Moltoni L, Biasi G, Marcolongo R (2000) Changes in intracellular calcium and magnesium ions in the physiopathology of the fybromyalgia syndrome. Minerva Med 91(7–8):137–140PubMedPubMedCentralGoogle Scholar
  33. 33.
    Abraham GE, Flechas JD (1992) Management of fibromyalgia: rationale for the use of magnesium and malic acid. Journal of Nutritional Medicine 3(1):49–59CrossRefGoogle Scholar
  34. 34.
    Dominguez LJ, Barbagallo M, Lauretani F, Bandinelli S, Bos A, Corsi AM, Simonsick EM, Ferrucci L (2006) Magnesium and muscle performance in older persons: the InCHIANTI study. Am J Clin Nutr 84(2):419–426CrossRefGoogle Scholar
  35. 35.
    Jahnen-Dechent W, Ketteler M (2012) Magnesium basics. Clin Kidney J 5(Suppl_1):i3–i14CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Medical Faculty, Department of Physiology, School of MedicineDokuz Eylul UniversityIzmirTurkey
  2. 2.College of Vocational School of Health Services, School of Medicine IzmirDokuz Eylul UniversityİzmirTurkey
  3. 3.Department of Medical Biology and Genetics, School of MedicineDokuz Eylul UniversityIzmirTurkey
  4. 4.Department of Psychiatry and PsychologyMayo ClinicRochesterUSA

Personalised recommendations